Pyrimidine compound as jak kinase inhibitor
AssigneeTheravance Biopharma R&D IP, LLC
InventorsJENNIFER KOZAK, RYAN HUDSON, GARY E.L. BRANDT, ROBERT MURRAY MCKINNELL
Life of this patent
Estimating the term…
Abstract
The invention provides a compound of formula (I): or a pharmaceutically-acceptable salt thereof, that is an inhibitor of JAK kinases. The invention also provides pharmaceutical compositions comprising such compound, a crystalline form, methods of using such compound to treat inflammatory skin diseases and other diseases, and processes and intermediates useful for preparing such compound.
Claims20
1-32. canceled
A method of treating an inflammatory skin disease in a mammal, the method comprising administering to the skin of the mammal a pharmaceutical composition comprising a compound of formula (I):
- or a pharmaceutically-acceptable salt thereof, and a pharmaceutically-acceptable carrier.
A method of treating an autoimmune skin disease in a mammal, the method comprising administering to the skin of the mammal a pharmaceutical composition comprising a compound of formula (I):
- or a pharmaceutically-acceptable salt thereof, and a pharmaceutically-acceptable carrier.
Dependencies are inferred from the claim text.